Variety Biosolution 4 Research & Healthcare Private Limited
Variety Biosolution 4 Research & Healthcare Private Limited is a Private Non-govt company company incorporated in 2021 and based in Andhra Pradesh, India. It was founded by John and Antaripa. Variety Biosolution 4 Research & Healthcare Private Limited operates in Medical & Precision (NIC 33110) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2023-24, the company reported revenue of ₹0 and a net loss of ₹6.11 L. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +14d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Variety Biosolution 4 Research & Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 564195554 | ICICI Bank Ltd(Bank) | ₹5.35 Cr | 19 Sep 2020 | Open |
| 715808468 | State Bank of India(Bank) | ₹23.77 Cr | 27 Jan 2021 | Open |
| 547992679 | State Bank of India(Bank) | ₹20.63 Cr | 19 Sep 2022 | Satisfied |
| 458638770 | State Bank of India(Bank) | ₹16.34 Cr | 12 Mar 2021 | Open |
| 654391443 | State Bank of India(Bank) | ₹20.23 Cr | 19 Sep 2019 | Open |
| 114686179 | HDFC Bank Ltd(Bank) | ₹13.80 Cr | 19 Sep 2022 | Open |
Charge IDs, lenders & amounts for Variety Biosolution 4 Research & Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2021-22 | — | ||||
| 2021-21 | — |
Detailed Financials
3 FYs| Line item | 2023-24 | 2021-22 | 2021-21 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | — | — | — | |
| Profit after Tax2023-24 | — | — | — | |
| Net Worth2023-24 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-21 | — | — | -4.36% | -0.84% | 5.17 | |||
| 2021-22 | — | — | — | -115.32% | — | |||
| 2023-24 | — | — | — | -80.29% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 3,31,53,808 | 87.63% |
| Institutional Investors | 1 | 15,10,802 | 3.99% |
| Public & Others | 43 | 31,67,700 | 8.37% |
Promoter, institutional & public holding for Variety Biosolution 4 Research & Healthcare Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
3 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.